Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”

BMC Proceedings

Proceedings

Bettina Prüller¹  Krutarth Patel²  Norbert Heinrich³  Celso Khosa⁴  Karlygash Abdiyeva⁵  Nurkeldi Turebekov⁵ 

[1] Center for International Health – CIHLMU, Munich, Germany;Center for International Health – CIHLMU, Munich, Germany;Alere Technologies GmbH, Jena, Germany;Center for International Health – CIHLMU, Munich, Germany;Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich, Munich, Germany;German Center for Infection Research (DZIF), Munich partner site, Munich, Germany;Center for International Health – CIHLMU, Munich, Germany;Instituto Nacional de Saúde, Maputo, Moçambique;Center for International Health – CIHLMU, Munich, Germany;Kazakh National Medical University, Almaty, Kazakhstan;

关键词: Multi-drug resistant tuberculosis;    Extensively drug-resistant tuberculosis;    Diagnosis;    Therapy;   

DOI  :  10.1186/s12919-017-0077-6

来源: Springer

【 摘 要 】

The 5th CIHLMU Infectious Disease Symposium, Munich, Germany, March 12, 2016 brought together Tuberculosis Experts from developed and low middle-income countries to discuss the control of drug resistance Tuberculosis. The meeting featured 9 presentations: Tuberculosis history and current scenario, Tuberculosis and migration - current scenario in Germany, Mechanism of Tuberculosis resistance development, Epidemiology of resistance – transmission vs. new generation of resistance, The impact of diagnostic in patients beyond – sensitivity and specificity, The Bangladesh regimen – new hope trough old drugs, New drugs and regimens – an overview on studies and Multi and Extensively Drug Resistant Tuberculosis from Europe. The presentations were followed by a panel discussion.Serious Multidrug Resistance epidemic in some countries may jeopardize the progress in Tuberculosis control. In this meeting epidemiology, mechanism, immigration and screening, diagnosis, research and treatment of drug resistant tuberculosis were discussed.

【 授权许可】

CC BY   
© The Author(s). 2017